Drug interaction analysis between 5-FdU-ECyd and cisplatin was based on cell viability data, obtained by the fluorometric Cell Titer Blue®-Assay (Promega, Fitchburg, USA), according to the manufacturer's instructions. Statistical analysis was performed by the combination index method [43], which is based on the combination of drugs at a broad range of equipotent molar concentrations or, as our modification, with standard cisplatin dose-response curves with a fixed 5-FdU-ECyd concentrations at each reading point. Additional information to this method is provided in Supplementary Materials.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.